Pfizer issues warning letter on Geodon antipsychotic drug

09/1/2004 | Forbes

The FDA and Pfizer have sent a warning letter to physicians advising them the antipsychotic drug Geodon is linked to high blood sugar and diabetes. The warning letter grew from an FDA investigation of six of the most widely used antipsychotic drugs and led to an instruction to the makers to revise their labels to reflect the dangers. The other drugs are AstraZeneca's Seroquel, Bristol-Myers Squibb's Abilify, Eli Lilly's Zyprexa, Janssen's Risperdal and Novartis' Clozaril.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA